When.com Web Search

  1. Ad

    related to: sonidegib odomzo

Search results

  1. Results From The WOW.Com Content Network
  2. Sonidegib - Wikipedia

    en.wikipedia.org/wiki/Sonidegib

    Sonidegib , sold under the brand name Odomzo, is a medication used to treat cancer. [ 1 ] Sonidegib is a Hedgehog signaling pathway inhibitor (via smoothened antagonism).

  3. Hedgehog pathway inhibitor - Wikipedia

    en.wikipedia.org/wiki/Hedgehog_pathway_inhibitor

    Sonidegib was created by Novartis. It is a SMO antagonist that can induce arrest of cell division and promote apoptosis in cancer cells. [ 14 ] Sonidegib has been effective in limiting the invasive potential of multiple cancer types including glioblastoma , [ 38 ] prostate cancer , [ 39 ] and renal cell carcinoma . [ 40 ]

  4. Hedgehog signaling pathway - Wikipedia

    en.wikipedia.org/wiki/Hedgehog_signaling_pathway

    Several hedgehog signaling pathway inhibitors are available for cancer treatment, such as vismodegib and sonidegib. These drugs are regarded as promising cancer therapies, especially for patients with refractory/advanced cancers. SMO inhibitors represent a potential treatment for some types of cancers.

  5. Vismodegib - Wikipedia

    en.wikipedia.org/wiki/Vismodegib

    Vismodegib, sold under the brand name Erivedge, is a medication used for the treatment of basal-cell carcinoma (BCC). [3] The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. [4]

  6. Category:Experimental cancer drugs - Wikipedia

    en.wikipedia.org/wiki/Category:Experimental...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us

  7. Vimseltinib - Wikipedia

    en.wikipedia.org/wiki/Vimseltinib

    This pharmacology -related article is a stub. You can help Wikipedia by expanding it.

  8. Gemtuzumab ozogamicin - Wikipedia

    en.wikipedia.org/wiki/Gemtuzumab_ozogamicin

    Mechanism of action of gemtuzumab ozogamicin. Gemtuzumab ozogamicin is a recombinant, humanized anti-CD33 monoclonal antibody (IgG4 κ antibody hP67.6) covalently attached to the cytotoxic antitumor antibiotic calicheamicin (N-acetyl-γ-calicheamicin) payload via a bifunctional linker (4-(4-acetylphenoxy)butanoic acid).

  9. Sacituzumab govitecan - Wikipedia

    en.wikipedia.org/wiki/Sacituzumab_govitecan

    Sacituzumab govitecan is indicated for the treatment of adults with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease; [11] people with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease; [14] and for people ...

  1. Ad

    related to: sonidegib odomzo